Compare · CCXI vs PRE

CCXI vs PRE

Side-by-side comparison of Churchill Capital Corp XI (CCXI) and Prenetics Global Limited (PRE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CCXI and PRE operate in Blank Checks (Finance), so they compete in similar markets.
  • PRE carries a market cap of $276.6M.
  • Over the past year, CCXI is up 8.8% and PRE is up 33.6% - PRE leads by 24.8 points.
  • CCXI has been more active in the news (40 items in the past 4 weeks vs 9 for PRE).
  • Both have 8 recent analyst ratings on file.
PerformanceCCXI+8.81%PRE+5.83%
2026-02-09+0.00%2026-11-04
MetricCCXIPRE
Company
Churchill Capital Corp XI
Prenetics Global Limited
Price
-
-
Market cap
-
$276.6M
1M return
-5.59%
-14.23%
1Y return
+8.81%
+33.58%
Industry
Blank Checks
Blank Checks
Exchange
NASDAQ
NASDAQ
IPO
2026
News (4w)
40
9
Recent ratings
8
8
CCXI

Churchill Capital Corp XI

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibitor for the treatment of anti-neutrophil cytoplasmic autoantibody-associated vasculitis; and completed Phase II clinical trial for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy. The company is also developing CCX559, an orally-administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally-administered inhibitor of the chemokine receptor CC9, which has completed Phase I clinical trial or the treatment of inflammatory bowel disease. In addition, it develops CCX587 for the treatment of TH17 driven diseases. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California.

Latest CCXI

Latest PRE